Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma-Lyte vs Saline and Infusion Speed in Critically Ill Patients
NCT02875873Phase 3Completed
- Sponsor
- HCor
- Start
- May 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plasma-lyte in critical illness, acute kidney injury (AKI), sponsored by HCor. Started May 2017; status: completed.
02
Drugs
plasma-lyte
03
Conditions
critical illnessacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02875873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875873.